Topotecan and Melphalan for Retinoblastoma

Clinical trial NCT04799002 · RECRUITING

Trial details

NCT number: NCT04799002
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Retinoblastoma Chemotherapy Effect

Start date: 2021-03-11
Primary completion: 2024-12-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.